尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Galli Stephen J, Director. Insider active across 1 company, notably Atossa Therapeutics, INC.. In total, 1 disclosures have been logged. History available since 12 May 2026. The latest transaction was filed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Stephen J. Galli is a Director at Atossa Therapeutics, Inc. He brings his expertise in strategy and governance to the board. Atossa Therapeutics is a company specializing in developing treatments for breast diseases. Mr. Galli plays an active role in strategic direction and oversight of the company's operations.